| Firas Qaqa, MD | |
|
111 Central Ave, Newark, NJ 07102-1909 | |
| (973) 877-5000 | |
| Not Available |
| Full Name | Firas Qaqa |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Interventional Cardiology |
| Location | 111 Central Ave, Newark, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659786606 | NPI | - | NPPES |
| Entity Name | Practice Associates Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427016385 PECOS PAC ID: 5890703177 Enrollment ID: O20060330000690 |
News Archive
Recent research from the Center for BrainHealth at The University of Texas at Dallas shows that cannabis users experience increased cortical activation during the brain's resting state when compared with nonusers.
"The key to India's success" in going a full year without recording a case of polio "was to take ownership of the problem and the solution, allowing for locals to learn from the expertise of the international community while not becoming dependent" on non-governmental organizations (NGOs) and international donors, William Thomson, a research assistant at the U.S. Naval War College, writes in The Diplomat's "India Decade."
There are approximately 500 species of cone snails, each producing 50 - 200 different conotoxins. A similar number of peptide toxins are produced by snakes, spiders, sea anemones, scorpions and other venomous animals. The animals use the neurotoxins to paralyze their prey.
With rates of Clostridium difficile (C. difficile) now rivaling drug-resistant Methicillin-resistant Staphylococcus aureus (MRSA) as the most common bacteria to cause healthcare-associated infections, new expert guidance encourages healthcare institutions to implement and prioritize prevention efforts for this infectious diarrhea.
Perrigo Company announced today that a federal court has granted summary judgment in its favor in patent litigation involving Guaifenesin Extended-Release Tablets, 600 mg, a generic version of Mucinex® tablets. Perrigo had been sued by Adams Respiratory Therapeutics, Inc., (a subsidiary of Reckitt Benckiser Group plc.) the New Drug Application holder and patent owner. The United States District Court for the Western District of Michigan ruled today that Perrigo does not infringe the patent in the suit. Perrigo's ANDA is awaiting FDA approval.
› Verified 7 days ago
| Entity Name | Excelcare Medical Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992736300 PECOS PAC ID: 4284647868 Enrollment ID: O20060727000044 |
News Archive
Recent research from the Center for BrainHealth at The University of Texas at Dallas shows that cannabis users experience increased cortical activation during the brain's resting state when compared with nonusers.
"The key to India's success" in going a full year without recording a case of polio "was to take ownership of the problem and the solution, allowing for locals to learn from the expertise of the international community while not becoming dependent" on non-governmental organizations (NGOs) and international donors, William Thomson, a research assistant at the U.S. Naval War College, writes in The Diplomat's "India Decade."
There are approximately 500 species of cone snails, each producing 50 - 200 different conotoxins. A similar number of peptide toxins are produced by snakes, spiders, sea anemones, scorpions and other venomous animals. The animals use the neurotoxins to paralyze their prey.
With rates of Clostridium difficile (C. difficile) now rivaling drug-resistant Methicillin-resistant Staphylococcus aureus (MRSA) as the most common bacteria to cause healthcare-associated infections, new expert guidance encourages healthcare institutions to implement and prioritize prevention efforts for this infectious diarrhea.
Perrigo Company announced today that a federal court has granted summary judgment in its favor in patent litigation involving Guaifenesin Extended-Release Tablets, 600 mg, a generic version of Mucinex® tablets. Perrigo had been sued by Adams Respiratory Therapeutics, Inc., (a subsidiary of Reckitt Benckiser Group plc.) the New Drug Application holder and patent owner. The United States District Court for the Western District of Michigan ruled today that Perrigo does not infringe the patent in the suit. Perrigo's ANDA is awaiting FDA approval.
› Verified 7 days ago
| Entity Name | Optum Medical Care Of New Jersey Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578665048 PECOS PAC ID: 3072650290 Enrollment ID: O20091021000129 |
News Archive
Recent research from the Center for BrainHealth at The University of Texas at Dallas shows that cannabis users experience increased cortical activation during the brain's resting state when compared with nonusers.
"The key to India's success" in going a full year without recording a case of polio "was to take ownership of the problem and the solution, allowing for locals to learn from the expertise of the international community while not becoming dependent" on non-governmental organizations (NGOs) and international donors, William Thomson, a research assistant at the U.S. Naval War College, writes in The Diplomat's "India Decade."
There are approximately 500 species of cone snails, each producing 50 - 200 different conotoxins. A similar number of peptide toxins are produced by snakes, spiders, sea anemones, scorpions and other venomous animals. The animals use the neurotoxins to paralyze their prey.
With rates of Clostridium difficile (C. difficile) now rivaling drug-resistant Methicillin-resistant Staphylococcus aureus (MRSA) as the most common bacteria to cause healthcare-associated infections, new expert guidance encourages healthcare institutions to implement and prioritize prevention efforts for this infectious diarrhea.
Perrigo Company announced today that a federal court has granted summary judgment in its favor in patent litigation involving Guaifenesin Extended-Release Tablets, 600 mg, a generic version of Mucinex® tablets. Perrigo had been sued by Adams Respiratory Therapeutics, Inc., (a subsidiary of Reckitt Benckiser Group plc.) the New Drug Application holder and patent owner. The United States District Court for the Western District of Michigan ruled today that Perrigo does not infringe the patent in the suit. Perrigo's ANDA is awaiting FDA approval.
› Verified 7 days ago
| Entity Name | Cogent Healthcare Of New Jersey Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629304290 PECOS PAC ID: 6608918867 Enrollment ID: O20100126000691 |
News Archive
Recent research from the Center for BrainHealth at The University of Texas at Dallas shows that cannabis users experience increased cortical activation during the brain's resting state when compared with nonusers.
"The key to India's success" in going a full year without recording a case of polio "was to take ownership of the problem and the solution, allowing for locals to learn from the expertise of the international community while not becoming dependent" on non-governmental organizations (NGOs) and international donors, William Thomson, a research assistant at the U.S. Naval War College, writes in The Diplomat's "India Decade."
There are approximately 500 species of cone snails, each producing 50 - 200 different conotoxins. A similar number of peptide toxins are produced by snakes, spiders, sea anemones, scorpions and other venomous animals. The animals use the neurotoxins to paralyze their prey.
With rates of Clostridium difficile (C. difficile) now rivaling drug-resistant Methicillin-resistant Staphylococcus aureus (MRSA) as the most common bacteria to cause healthcare-associated infections, new expert guidance encourages healthcare institutions to implement and prioritize prevention efforts for this infectious diarrhea.
Perrigo Company announced today that a federal court has granted summary judgment in its favor in patent litigation involving Guaifenesin Extended-Release Tablets, 600 mg, a generic version of Mucinex® tablets. Perrigo had been sued by Adams Respiratory Therapeutics, Inc., (a subsidiary of Reckitt Benckiser Group plc.) the New Drug Application holder and patent owner. The United States District Court for the Western District of Michigan ruled today that Perrigo does not infringe the patent in the suit. Perrigo's ANDA is awaiting FDA approval.
› Verified 7 days ago
| Entity Name | Hospitalist Medicine Physicians Of New Jersey - Paterson, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821576455 PECOS PAC ID: 1153671383 Enrollment ID: O20180907002361 |
News Archive
Recent research from the Center for BrainHealth at The University of Texas at Dallas shows that cannabis users experience increased cortical activation during the brain's resting state when compared with nonusers.
"The key to India's success" in going a full year without recording a case of polio "was to take ownership of the problem and the solution, allowing for locals to learn from the expertise of the international community while not becoming dependent" on non-governmental organizations (NGOs) and international donors, William Thomson, a research assistant at the U.S. Naval War College, writes in The Diplomat's "India Decade."
There are approximately 500 species of cone snails, each producing 50 - 200 different conotoxins. A similar number of peptide toxins are produced by snakes, spiders, sea anemones, scorpions and other venomous animals. The animals use the neurotoxins to paralyze their prey.
With rates of Clostridium difficile (C. difficile) now rivaling drug-resistant Methicillin-resistant Staphylococcus aureus (MRSA) as the most common bacteria to cause healthcare-associated infections, new expert guidance encourages healthcare institutions to implement and prioritize prevention efforts for this infectious diarrhea.
Perrigo Company announced today that a federal court has granted summary judgment in its favor in patent litigation involving Guaifenesin Extended-Release Tablets, 600 mg, a generic version of Mucinex® tablets. Perrigo had been sued by Adams Respiratory Therapeutics, Inc., (a subsidiary of Reckitt Benckiser Group plc.) the New Drug Application holder and patent owner. The United States District Court for the Western District of Michigan ruled today that Perrigo does not infringe the patent in the suit. Perrigo's ANDA is awaiting FDA approval.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Firas Qaqa, MD 200 Riverwalk Way, Clifton, NJ 07014-1733 Ph: (312) 945-1543 | Firas Qaqa, MD 111 Central Ave, Newark, NJ 07102-1909 Ph: (973) 877-5000 |
News Archive
Recent research from the Center for BrainHealth at The University of Texas at Dallas shows that cannabis users experience increased cortical activation during the brain's resting state when compared with nonusers.
"The key to India's success" in going a full year without recording a case of polio "was to take ownership of the problem and the solution, allowing for locals to learn from the expertise of the international community while not becoming dependent" on non-governmental organizations (NGOs) and international donors, William Thomson, a research assistant at the U.S. Naval War College, writes in The Diplomat's "India Decade."
There are approximately 500 species of cone snails, each producing 50 - 200 different conotoxins. A similar number of peptide toxins are produced by snakes, spiders, sea anemones, scorpions and other venomous animals. The animals use the neurotoxins to paralyze their prey.
With rates of Clostridium difficile (C. difficile) now rivaling drug-resistant Methicillin-resistant Staphylococcus aureus (MRSA) as the most common bacteria to cause healthcare-associated infections, new expert guidance encourages healthcare institutions to implement and prioritize prevention efforts for this infectious diarrhea.
Perrigo Company announced today that a federal court has granted summary judgment in its favor in patent litigation involving Guaifenesin Extended-Release Tablets, 600 mg, a generic version of Mucinex® tablets. Perrigo had been sued by Adams Respiratory Therapeutics, Inc., (a subsidiary of Reckitt Benckiser Group plc.) the New Drug Application holder and patent owner. The United States District Court for the Western District of Michigan ruled today that Perrigo does not infringe the patent in the suit. Perrigo's ANDA is awaiting FDA approval.
› Verified 7 days ago
Dr. Xiaoning Joanie Zhu, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 741 Broadway, Newark, NJ 07104 Phone: 973-481-1300 | |
Lissette Maria Cespedes, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 185 S Orange Ave, Msb I588, Newark, NJ 07103 Phone: 973-972-3479 | |
Dr. Pankaja Achar, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 194 Clinton Ave Fl 2, Newark, NJ 07108 Phone: 973-273-1515 Fax: 973-230-0883 | |
Marc H. Lavietes, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 90 Bergen St, Doc 4500, Newark, NJ 07103 Phone: 973-972-2500 Fax: 973-972-2510 | |
Dr. Hoi-wing Susanna Yim, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 111 Central Ave, Newark, NJ 07102 Phone: 973-877-5000 | |
Tharakeswari Selvakumar, MD, PHD Internal Medicine Medicare: Medicare Enrolled Practice Location: 150 Bergen St # Uhi-248, Newark, NJ 07103 Phone: 973-972-6056 | |
Dr. Epifania Lopez Ramirez, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 1119 Broad St, Newark, NJ 07114 Phone: 973-824-8226 Fax: 973-824-0193 |